A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
Jazz Pharmaceuticals
Trishula Therapeutics, Inc.
NGM Biopharmaceuticals, Inc
Eli Lilly and Company
Cantargia AB
Canadian Cancer Trials Group
Cantargia AB
Eli Lilly and Company
Incyte Corporation
Wake Forest University Health Sciences
Gilead Sciences
TG Therapeutics, Inc.
Masonic Cancer Center, University of Minnesota
Northwestern University
Vejle Hospital
University of Southern California
Seoul National University Bundang Hospital
National Institutes of Health Clinical Center (CC)
Eli Lilly and Company
Royal Marsden NHS Foundation Trust